Leveraging Public Private Partnerships to Address Global Vaccine Needs Evaluation of the Merck-Wellcome Trust Hilleman Laboratories

This report offers an evaluation of Merck-Wellcome Trust Hilleman Laboratories (Hilleman Laboratories or the labs), a public private venture launched in 2009 by the Wellcome Trust and Merck & Co., Inc. (Merck), intended to contribute to the development of high-impact, affordable vaccines for people in developing countries. As a starting point, this report offers context on the global burden of infectious disease, borne disproportionately by people living in the developing world, and discusses related challenges in developing, deploying, and financing vaccines to address this burden.